Data for: A 73-gene Proliferative Transcriptomic Signature Predicts Uterine Serous Carcinoma Patient Survival and Response to Primary Therapy
Published: 7 May 2020| Version 1 | DOI: 10.17632/kjmmvtdssg.1
Contributors:
Jin-Xiong She, Description
De-identified uterine serous carcinoma patients' gene expression information and clinicodemographic information.
Files
Categories
Transcriptomics, Gynecologic Pathology, Biomarker Validation